Biobanking Survey

 The growth of the genomics industry

 Increased popularity of at-home genetic tests

 Growth of precision medicine applications

 New products and technologies making it more possible to share samples

 An increase in consumer samples

 A greater need for better treatments

 A lack of funding

 Inefficient technology

 A lack of reliable and cost-effective samples

 Insufficient regulations/regulatory bodies

 Inability to quickly track down specific samples for research

 Improved cloud technologies for real-time sharing to improve collaboration

 Better sample storage and tracking technology

 Big data complemented with medical imaging

 Machine learning algorithms

 Artificial intelligence for bioresource collection and utilization

 Clear communication around how their sample will be used

 A sample disclosure form to ensure alignment on sample use

 Improved education on the impact their sample(s) will have on improving healthcare

 More reliable genetic testing options